Lomefloxacin concentration in human prostatic tissue following 3-day administration

The penetration of Lomefloxacin (LFLX) into the prostatic tissue and the serum were examined. Forty four patients with benign prostatic hypertrophy treated with transurethral resection of the prostate (TUR-P) were entered in this study. LFLX was administered orally in a dose of 200 mg three times da...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 1 vom: 15. Jan., Seite 97-9
1. Verfasser: Morita, M (VerfasserIn)
Weitere Verfasser: Hatakeyama, T, Suzuki, K
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1993
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Anti-Infective Agents Fluoroquinolones Quinolones lomefloxacin L6BR2WJD8V
Beschreibung
Zusammenfassung:The penetration of Lomefloxacin (LFLX) into the prostatic tissue and the serum were examined. Forty four patients with benign prostatic hypertrophy treated with transurethral resection of the prostate (TUR-P) were entered in this study. LFLX was administered orally in a dose of 200 mg three times daily for three days preoperatively. The blood samples were taken simultaneously at the time of the tissue sampling. The patients were divided into groups 1 and 2. In group 1 (seventeen patients), the tissue sampling was done about 17 hours after the final drug administration. The mean concentration of LFLX was 3.31 +/- 1.16 micrograms/g in the prostatic tissue and 1.70 +/- 0.56 micrograms/ml in the serum. In group 2 (twenty seven patients), tissue sampling was done 5.5 hours after the final drug administration. The mean concentration of LFLX was 5.70 +/- 2.28 micrograms/g in the prostatic tissue and 2.93 +/- 1.14 micrograms/ml in the serum
Beschreibung:Date Completed 23.04.1993
Date Revised 15.11.2012
published: Print
Citation Status MEDLINE
ISSN:0018-1994